Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4879535 Target Snapshot

Protein cereblon/Cyclin-dependent kinase 12 · PROTEIN-PROTEIN INTERACTION · Homo sapiens

55Compounds
20Assays
0Approved Drugs
11.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9NYV4. Use UniProt Q9NYV4 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9NYV4 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Protein cereblon/Cyclin-dependent kinase 12 as ChEMBL target CHEMBL4879535, mapped to UniProt Q9NYV4. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Protein cereblon/Cyclin-dependent kinase 12
PROTEIN-PROTEIN INTERACTION · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4879535
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9NYV4
Cyclin-dependent kinase 12
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Protein cereblon/Cyclin-dependent kinase 12 is the right protein anchor across sources, using UniProt Q9NYV4 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCyclin-dependent kinase 12
UniProt AccessionQ9NYV4
Component TypeProtein
Sequence Length1490 aa

Cyclin-dependent kinase 12

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Protein cereblon/Cyclin-dependent kinase 12, mapped to UniProt Q9NYV4. ChEMBL maps the protein component as Cyclin-dependent kinase 12. Sequence length is 1490 aa.

Mapped IDQ9NYV4
Review nameProtein cereblon/Cyclin-dependent kinase 12
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC503.0
EC508.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5178057 8.66 EC50 2.2 Preclinical
CHEMBL5184280 8.41 EC50 3.9 Preclinical
CHEMBL5200971 8.36 EC50 4.4 Preclinical
CHEMBL5182667 8.26 EC50 5.5 Preclinical
CHEMBL5420004 8.22 IC50 6.0 Preclinical
CHEMBL5205494 8.17 EC50 6.8 Preclinical
CHEMBL5424163 8.05 IC50 9.0 Preclinical
CHEMBL5193459 7.71 EC50 19.3 Preclinical
CHEMBL5179163 7.48 EC50 33.1 Preclinical
CHEMBL5186403 7.45 EC50 35.5 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
0
6.0
1
6.5
2
7.0
1
7.5
6
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

20
Total Assays
11
Tested Compounds
1
Assay Types
Binding — 20 assays, 11 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 19 11 8.0
protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine